The effect of varicella-zoster virus reactivation on the long-term outcomes of patients undergoing allogeneic hematopoietic stem cell transplantation

Abstract Background A virus infection may lead the body to produce more immune cells of particular types or stimulate the production of new ones, both of which may have anti-leukemic effects. There has been no research on whether immune cells stimulated by varicella-zoster virus (VZV) infection have...

Full description

Bibliographic Details
Main Authors: Ping Li, Jingxia Li, Haoyuan Huang, Xiongnong Chen, Yue Lin, Ganlin He, Duorong Xu
Format: Article
Language:English
Published: BMC 2023-10-01
Series:Journal of Health, Population and Nutrition
Subjects:
Online Access:https://doi.org/10.1186/s41043-023-00429-8
_version_ 1827633819089371136
author Ping Li
Jingxia Li
Haoyuan Huang
Xiongnong Chen
Yue Lin
Ganlin He
Duorong Xu
author_facet Ping Li
Jingxia Li
Haoyuan Huang
Xiongnong Chen
Yue Lin
Ganlin He
Duorong Xu
author_sort Ping Li
collection DOAJ
description Abstract Background A virus infection may lead the body to produce more immune cells of particular types or stimulate the production of new ones, both of which may have anti-leukemic effects. There has been no research on whether immune cells stimulated by varicella-zoster virus (VZV) infection have anti-leukemic effects. The objective of this investigation is to assess the impact of VZV infection on patients' long-term survival following allogeneic hematopoietic stem cell transplantation (allo-HSCT). Methods This retrospective study investigated the association between varicella-zoster virus (VZV) reactivation and outcomes in 219 individuals who received allogeneic hematopoietic stem cell transplantation (allo-HSCT) at the Sun Yat-sen University’s First Affiliated Hospital. According to being diagnosed with VZV infection or not, these patients were grouped into two groups. The comparison of cumulative incidence of relapse, non-recurrent mortality, and overall survival (OS) was conducted between the two groups. Results Analyzing multivariate data, VZV reactivation was linked to lower relapse incidence in the group containing all individuals (hazard ratio [HR] = 0.27; 95% confidence interval [CI], 0.12–0.64), patients suffering from acute myeloid leukaemia (HR = 0.10; 95% CI, 0.01–0.83), and patients suffering from acute lymphoblastic leukaemia (HR = 0.25; 95% CI, 0.08–0.77). Moreover, VZV reactivation was linked with decreased non-relapse mortality in all individuals (HR = 0.20; 95% CI, 0.05–0.79), but no statistical significance was found for any disease subgroup. Further, VZV reactivation was an independent predictor for improved OS in the group containing all individuals (HR = 0.10; 95% CI, 0.03–0.29), patients suffering from acute myeloid leukaemia (HR = 0.09; 95% CI, 0.01–0.66), and patients suffering from acute lymphoblastic leukaemia (HR = 0.16; 95% CI, 0.04–0.68). Conclusion This is the first study to show that VZV reactivation following allo-HSCT is an independent predictor for lower relapse rates and improved OS, providing novel therapeutic approaches to improve patients’ long-term survival following allo-HSCT.
first_indexed 2024-03-09T15:04:49Z
format Article
id doaj.art-51df75d43d3644bcba993330bb4ae1e6
institution Directory Open Access Journal
issn 2072-1315
language English
last_indexed 2024-03-09T15:04:49Z
publishDate 2023-10-01
publisher BMC
record_format Article
series Journal of Health, Population and Nutrition
spelling doaj.art-51df75d43d3644bcba993330bb4ae1e62023-11-26T13:41:38ZengBMCJournal of Health, Population and Nutrition2072-13152023-10-0142111010.1186/s41043-023-00429-8The effect of varicella-zoster virus reactivation on the long-term outcomes of patients undergoing allogeneic hematopoietic stem cell transplantationPing Li0Jingxia Li1Haoyuan Huang2Xiongnong Chen3Yue Lin4Ganlin He5Duorong Xu6Department of Haematology, The First Affiliated Hospital of Sun Yat-sen UniversityDepartment of Haematology, The First Affiliated Hospital of Sun Yat-sen UniversityDepartment of Haematology, The First Affiliated Hospital of Sun Yat-sen UniversityDepartment of Haematology, The First Affiliated Hospital of Sun Yat-sen UniversityDepartment of Haematology, The First Affiliated Hospital of Sun Yat-sen UniversityDepartment of Haematology, The First Affiliated Hospital of Sun Yat-sen UniversityDepartment of Haematology, The First Affiliated Hospital of Sun Yat-sen UniversityAbstract Background A virus infection may lead the body to produce more immune cells of particular types or stimulate the production of new ones, both of which may have anti-leukemic effects. There has been no research on whether immune cells stimulated by varicella-zoster virus (VZV) infection have anti-leukemic effects. The objective of this investigation is to assess the impact of VZV infection on patients' long-term survival following allogeneic hematopoietic stem cell transplantation (allo-HSCT). Methods This retrospective study investigated the association between varicella-zoster virus (VZV) reactivation and outcomes in 219 individuals who received allogeneic hematopoietic stem cell transplantation (allo-HSCT) at the Sun Yat-sen University’s First Affiliated Hospital. According to being diagnosed with VZV infection or not, these patients were grouped into two groups. The comparison of cumulative incidence of relapse, non-recurrent mortality, and overall survival (OS) was conducted between the two groups. Results Analyzing multivariate data, VZV reactivation was linked to lower relapse incidence in the group containing all individuals (hazard ratio [HR] = 0.27; 95% confidence interval [CI], 0.12–0.64), patients suffering from acute myeloid leukaemia (HR = 0.10; 95% CI, 0.01–0.83), and patients suffering from acute lymphoblastic leukaemia (HR = 0.25; 95% CI, 0.08–0.77). Moreover, VZV reactivation was linked with decreased non-relapse mortality in all individuals (HR = 0.20; 95% CI, 0.05–0.79), but no statistical significance was found for any disease subgroup. Further, VZV reactivation was an independent predictor for improved OS in the group containing all individuals (HR = 0.10; 95% CI, 0.03–0.29), patients suffering from acute myeloid leukaemia (HR = 0.09; 95% CI, 0.01–0.66), and patients suffering from acute lymphoblastic leukaemia (HR = 0.16; 95% CI, 0.04–0.68). Conclusion This is the first study to show that VZV reactivation following allo-HSCT is an independent predictor for lower relapse rates and improved OS, providing novel therapeutic approaches to improve patients’ long-term survival following allo-HSCT.https://doi.org/10.1186/s41043-023-00429-8Allogeneic hematopoietic stem cell transplantationVaricella-zoster virus reactivationRelapseOverall survival
spellingShingle Ping Li
Jingxia Li
Haoyuan Huang
Xiongnong Chen
Yue Lin
Ganlin He
Duorong Xu
The effect of varicella-zoster virus reactivation on the long-term outcomes of patients undergoing allogeneic hematopoietic stem cell transplantation
Journal of Health, Population and Nutrition
Allogeneic hematopoietic stem cell transplantation
Varicella-zoster virus reactivation
Relapse
Overall survival
title The effect of varicella-zoster virus reactivation on the long-term outcomes of patients undergoing allogeneic hematopoietic stem cell transplantation
title_full The effect of varicella-zoster virus reactivation on the long-term outcomes of patients undergoing allogeneic hematopoietic stem cell transplantation
title_fullStr The effect of varicella-zoster virus reactivation on the long-term outcomes of patients undergoing allogeneic hematopoietic stem cell transplantation
title_full_unstemmed The effect of varicella-zoster virus reactivation on the long-term outcomes of patients undergoing allogeneic hematopoietic stem cell transplantation
title_short The effect of varicella-zoster virus reactivation on the long-term outcomes of patients undergoing allogeneic hematopoietic stem cell transplantation
title_sort effect of varicella zoster virus reactivation on the long term outcomes of patients undergoing allogeneic hematopoietic stem cell transplantation
topic Allogeneic hematopoietic stem cell transplantation
Varicella-zoster virus reactivation
Relapse
Overall survival
url https://doi.org/10.1186/s41043-023-00429-8
work_keys_str_mv AT pingli theeffectofvaricellazostervirusreactivationonthelongtermoutcomesofpatientsundergoingallogeneichematopoieticstemcelltransplantation
AT jingxiali theeffectofvaricellazostervirusreactivationonthelongtermoutcomesofpatientsundergoingallogeneichematopoieticstemcelltransplantation
AT haoyuanhuang theeffectofvaricellazostervirusreactivationonthelongtermoutcomesofpatientsundergoingallogeneichematopoieticstemcelltransplantation
AT xiongnongchen theeffectofvaricellazostervirusreactivationonthelongtermoutcomesofpatientsundergoingallogeneichematopoieticstemcelltransplantation
AT yuelin theeffectofvaricellazostervirusreactivationonthelongtermoutcomesofpatientsundergoingallogeneichematopoieticstemcelltransplantation
AT ganlinhe theeffectofvaricellazostervirusreactivationonthelongtermoutcomesofpatientsundergoingallogeneichematopoieticstemcelltransplantation
AT duorongxu theeffectofvaricellazostervirusreactivationonthelongtermoutcomesofpatientsundergoingallogeneichematopoieticstemcelltransplantation
AT pingli effectofvaricellazostervirusreactivationonthelongtermoutcomesofpatientsundergoingallogeneichematopoieticstemcelltransplantation
AT jingxiali effectofvaricellazostervirusreactivationonthelongtermoutcomesofpatientsundergoingallogeneichematopoieticstemcelltransplantation
AT haoyuanhuang effectofvaricellazostervirusreactivationonthelongtermoutcomesofpatientsundergoingallogeneichematopoieticstemcelltransplantation
AT xiongnongchen effectofvaricellazostervirusreactivationonthelongtermoutcomesofpatientsundergoingallogeneichematopoieticstemcelltransplantation
AT yuelin effectofvaricellazostervirusreactivationonthelongtermoutcomesofpatientsundergoingallogeneichematopoieticstemcelltransplantation
AT ganlinhe effectofvaricellazostervirusreactivationonthelongtermoutcomesofpatientsundergoingallogeneichematopoieticstemcelltransplantation
AT duorongxu effectofvaricellazostervirusreactivationonthelongtermoutcomesofpatientsundergoingallogeneichematopoieticstemcelltransplantation